Antenatal corticosteroids: a risk factor for the development of chronic disease

Elizabeth Asztalos1

  • 1Department of Paediatrics, University of Toronto and The Centre for Mother, Infant, and Child Research, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5.

Insights

Antenatal corticosteroids (ACS) given during pregnancy to promote fetal lung maturity may lead to lower birth weight and long-term health issues. Research is exploring the lasting effects of ACS on fetal development and adult health outcomes.

Area of Science:

  • Perinatology
  • Developmental programming
  • Endocrinology

Background:

  • Preterm birth is a significant global health concern.
  • Antenatal corticosteroids (ACS) are used to accelerate fetal lung maturity in at-risk pregnancies.
  • Repeated courses of ACS are increasingly administered for ongoing preterm birth risk.

Purpose of the Study:

  • To investigate the potential long-term consequences of exogenous ACS exposure on fetal development.
  • To examine the association between ACS administration and adverse adult health outcomes.
  • To explore the impact of ACS on the hypothalamic-pituitary-adrenal (HPA) axis and neurological function.

Main Methods:

  • Review of existing animal studies on ACS effects on HPA axis and neurological function.
  • Analysis of human studies examining developmental programming related to ACS exposure.
  • Correlation of birth weight changes with adult chronic illnesses and behavioral patterns.

Main Results:

  • Animal studies indicate that ACS exposure can cause permanent alterations in fetal HPA axis development.
  • Reduced birth weight following ACS exposure is linked to increased risks of coronary heart disease, stroke, hypertension, and type 2 diabetes in adulthood.
  • Evidence suggests potential lifelong changes in HPA axis activity and neurological function due to ACS.

Conclusions:

  • Exogenous ACS, while beneficial for fetal lung maturity, may have lasting adverse effects on development.
  • Further human studies are crucial to confirm the link between in-utero ACS exposure and long-term health programming.
  • Understanding these developmental impacts is essential for optimizing antenatal corticosteroid use in high-risk pregnancies.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...